Latest Regulatory Compliance News

Desert Metals Limited has completed the first tranche of its capital raising, issuing 64 million shares to raise $416,000, with a shareholder meeting planned to approve a second tranche worth $834,000.

Embark Early Education has successfully completed a $12 million placement to support its conditional takeover bid for Mayfield Childcare. The capital raise attracted strong backing from existing and new sophisticated investors.

The ASX has suspended trading of Olympio Metals and Thorney Technologies shares due to delayed periodic report filings, highlighting ongoing compliance challenges for both companies.

Biotron Limited’s BITO securities have been suspended from ASX trading due to non-compliance with key listing rules, raising questions about the company’s next steps.

Nova Minerals Limited has voluntarily suspended trading of its shares on the ASX pending a capital raising announcement expected on 17 December 2025.

Tasman Resources has completed the second tranche of its $2 million share placement, issuing 92 million shares and raising $1.15 million before costs. The company confirms full compliance with regulatory requirements in its updated cleansing notice.

Xstate Resources has launched a prospectus offering nearly 97 million free attaching options to placement participants and contractors, alongside a nominal cleansing offer to remove trading restrictions on recent share issuances.

Assetora Limited has updated its previous placement announcements, confirming that the issuance of shares to Cardio Link and Creative Capital Management will now require shareholder approval at an upcoming EGM likely scheduled for late January 2026.

Metal Bank Limited addresses ASX concerns over recent share price volatility, confirming a pending Mineral Resource Estimate announcement and recent strategic moves as key drivers.

NEXTDC has responded to ASX concerns over early media disclosures about its $7 billion OpenAI data centre deal, affirming compliance with continuous disclosure rules and downplaying price sensitivity.

Lycopodium Limited has addressed ASX concerns over delayed director interest disclosures, attributing the lapse to an administrative oversight while reaffirming its compliance policies.

RMA Global Limited has firmly denied allegations of selective disclosure following a December 4 webinar that coincided with a notable share price rise. The company insists no new price sensitive information was shared beyond prior ASX announcements.